BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11805130)

  • 1. Beta2 integrins are required for skin homing of primed T cells but not for priming naive T cells.
    Grabbe S; Varga G; Beissert S; Steinert M; Pendl G; Seeliger S; Bloch W; Peters T; Schwarz T; Sunderkötter C; Scharffetter-Kochanek K
    J Clin Invest; 2002 Jan; 109(2):183-92. PubMed ID: 11805130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired cutaneous immune responses in Thy-1-deficient mice.
    Beissert S; He HT; Hueber AO; Lellouch AC; Metze D; Mehling A; Luger TA; Schwarz T; Grabbe S
    J Immunol; 1998 Nov; 161(10):5296-302. PubMed ID: 9820502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins.
    Kuijpers TW; Van Lier RA; Hamann D; de Boer M; Thung LY; Weening RS; Verhoeven AJ; Roos D
    J Clin Invest; 1997 Oct; 100(7):1725-33. PubMed ID: 9312170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage.
    Scholzen TE; Steinhoff M; Sindrilaru A; Schwarz A; Bunnett NW; Luger TA; Armstrong CA; Ansel JC
    FASEB J; 2004 Jun; 18(9):1007-9. PubMed ID: 15084523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal T Cell Activation and B Cell Antibody Responses In Vivo Require the Interaction between Leukocyte Function-Associated Antigen-1 and Kindlin-3.
    Morrison VL; Uotila LM; Llort Asens M; Savinko T; Fagerholm SC
    J Immunol; 2015 Jul; 195(1):105-15. PubMed ID: 25987740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1beta, but not IL-1alpha, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses.
    Nambu A; Nakae S; Iwakura Y
    Int Immunol; 2006 May; 18(5):701-12. PubMed ID: 16569679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophils migrate to delayed-type hypersensitivity reactions in joints, but not in skin. Mechanism is leukocyte function-associated antigen-1-/Mac-1-independent.
    Gao JX; Issekutz AC; Issekutz TB
    J Immunol; 1994 Dec; 153(12):5689-97. PubMed ID: 7989766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of contact hypersensitivity in the mouse model.
    Martin SF
    Methods Mol Biol; 2013; 961():325-35. PubMed ID: 23325654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
    Miller SD; Butler LD
    J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Beta2-Integrins Restrict Skin Inflammation In Vivo.
    Savinko TS; Morrison VL; Uotila LM; Wolff CHJ; Alenius HT; Fagerholm SC
    J Invest Dermatol; 2015 Sep; 135(9):2249-2257. PubMed ID: 25918984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential requirement for CD18 in T-helper effector homing.
    Lee SH; Prince JE; Rais M; Kheradmand F; Shardonofsky F; Lu H; Beaudet AL; Smith CW; Soong L; Corry DB
    Nat Med; 2003 Oct; 9(10):1281-6. PubMed ID: 14502280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-10 controls dendritic cell-induced T-cell reactivation in the skin to limit contact hypersensitivity.
    Girard-Madoux MJ; Kel JM; Reizis B; Clausen BE
    J Allergy Clin Immunol; 2012 Jan; 129(1):143-50.e1-10. PubMed ID: 21975175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired contact hypersensitivity in macrophage migration inhibitory factor-deficient mice.
    Shimizu T; Abe R; Nishihira J; Shibaki A; Watanabe H; Nakayama T; Taniguchi M; Ishibashi T; Shimizu H
    Eur J Immunol; 2003 Jun; 33(6):1478-87. PubMed ID: 12778465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the CD28 molecule to allergic and irritant-induced skin reactions in CD28 -/- mice.
    Kondo S; Kooshesh F; Wang B; Fujisawa H; Sauder DN
    J Immunol; 1996 Dec; 157(11):4822-9. PubMed ID: 8943384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation of delayed-type hypersensitivity responses by mesenchymal stem cells is associated with bystander T cell apoptosis in the draining lymph node.
    Lim JH; Kim JS; Yoon IH; Shin JS; Nam HY; Yang SH; Kim SJ; Park CG
    J Immunol; 2010 Oct; 185(7):4022-9. PubMed ID: 20802154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells.
    Moll H; Fuchs H; Blank C; Röllinghoff M
    Eur J Immunol; 1993 Jul; 23(7):1595-601. PubMed ID: 8325337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminal B cell differentiation is skewed by deregulated interleukin-6 secretion in beta2 integrin-deficient mice.
    Peters T; Bloch W; Wickenhauser C; Tawadros S; Oreshkova T; Kess D; Krieg T; Müller W; Scharffetter-Kochanek K
    J Leukoc Biol; 2006 Sep; 80(3):599-607. PubMed ID: 16844762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired contact hypersensitivity in diet-induced obese mice.
    Katagiri K; Arakawa S; Kurahashi R; Hatano Y
    J Dermatol Sci; 2007 May; 46(2):117-26. PubMed ID: 17350227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of inflammation by collagen-binding integrins alpha1beta1 and alpha2beta1 in models of hypersensitivity and arthritis.
    de Fougerolles AR; Sprague AG; Nickerson-Nutter CL; Chi-Rosso G; Rennert PD; Gardner H; Gotwals PJ; Lobb RR; Koteliansky VE
    J Clin Invest; 2000 Mar; 105(6):721-9. PubMed ID: 10727440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.